Aberdeen Asset Management plc Given Overweight Rating at JPMorgan Chase & Co. (ADN)
Aberdeen Asset Management plc (LON:ADN)‘s stock had its “overweight” rating restated by analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Monday. They currently have a GBX 520 ($8.83) price objective on the stock. JPMorgan Chase & Co.’s price objective points to a potential upside of 19.54% from the stock’s previous close.
Shares of Aberdeen Asset Management plc (LON:ADN) traded down 5.31% on Monday, hitting GBX 435.00. The stock had a trading volume of 9,079,206 shares. Aberdeen Asset Management plc has a 52-week low of GBX 342.60 and a 52-week high of GBX 500.00. The stock’s 50-day moving average is GBX 449. and its 200-day moving average is GBX 424.9. The company’s market cap is £4.985 billion.
Several other analysts have also recently commented on the stock. Analysts at Espirito Santo Investment Bank Research reiterated a “buy” rating on shares of Aberdeen Asset Management plc in a research note on Tuesday, July 22nd. They now have a GBX 550 ($9.34) price target on the stock. Separately, analysts at Barclays reiterated an “overweight” rating on shares of Aberdeen Asset Management plc in a research note on Thursday, July 10th. Finally, analysts at HSBC upgraded shares of Aberdeen Asset Management plc to an “overweight” rating in a research note on Tuesday, July 8th. They now have a GBX 525 ($8.91) price target on the stock. Three analysts have rated the stock with a sell rating, four have assigned a hold rating and thirteen have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of GBX 473.47 ($8.04).
Aberdeen Asset Management PLC is a global asset management company investing across the four main asset classes of equity, fixed income, property and alternative investment strategies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.